Endothelial function and dysfunction: Impact of metformin

[1]  Metformin , 2019, Reactions Weekly.

[2]  P. Newsholme,et al.  Epigenetic effects of metformin: From molecular mechanisms to clinical implications , 2018, Diabetes, obesity & metabolism.

[3]  P. Little,et al.  Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects , 2018, Theranostics.

[4]  C. Hung,et al.  Suppressive effects of metformin on T-helper 1-related chemokines expression in the human monocytic leukemia cell line THP-1 , 2018, Endocrine research.

[5]  N. Jain,et al.  Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[6]  Jing Cai,et al.  Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation , 2018, International journal of oncology.

[7]  P. Little,et al.  Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen , 2018, Medicinal research reviews.

[8]  R. Henning,et al.  Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from Glycemia Control: Comparison to Vildagliptin , 2017, Scientific Reports.

[9]  Sara Lee.  Update on SGLT2 Inhibitors-New Data Released at the American Diabetes Association. , 2017, Critical pathways in cardiology.

[10]  Hanqing Li,et al.  REM sleep deprivation induces endothelial dysfunction and hypertension in middle-aged rats: Roles of the eNOS/NO/cGMP pathway and supplementation with L-arginine , 2017, PloS one.

[11]  R. Klein,et al.  Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. , 2017, The lancet. Diabetes & endocrinology.

[12]  Arijit Ghosh,et al.  Role of free fatty acids in endothelial dysfunction , 2017, Journal of Biomedical Science.

[13]  Daowen Wang,et al.  Liver Kinase B1/AMP-Activated Protein Kinase Pathway Activation Attenuated the Progression of Endotoxemia in the Diabetic Mice , 2017, Cellular Physiology and Biochemistry.

[14]  P. Little,et al.  The emerging role of metformin in gestational diabetes mellitus , 2017, Diabetes, obesity & metabolism.

[15]  S. Samuel,et al.  Metformin represses glucose starvation induced autophagic response in microvascular endothelial cells and promotes cell death , 2017, Biochemical pharmacology.

[16]  F. Lapi,et al.  Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications , 2017, Therapeutic advances in drug safety.

[17]  R. Wei,et al.  Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway , 2017, Scientific Reports.

[18]  C. Triggle,et al.  Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium , 2017, Acta physiologica.

[19]  Z. Li,et al.  Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation , 2016, PloS one.

[20]  Yuepu Pu,et al.  Inhibition of Glucose-6-Phosphate Dehydrogenase Could Enhance 1,4-Benzoquinone-Induced Oxidative Damage in K562 Cells , 2016, Oxidative medicine and cellular longevity.

[21]  Xian Wang,et al.  Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase. , 2016, Journal of diabetes and its complications.

[22]  Guojun Jiang,et al.  Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice , 2016, Cardiovascular Diabetology.

[23]  P. He,et al.  Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis , 2016, PloS one.

[24]  Chih-Hung Lee,et al.  Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis. , 2016, Frontiers in bioscience.

[25]  R. DeFronzo,et al.  Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials , 2016, Diabetologia.

[26]  G. Garcı́a-Cardeña,et al.  Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. , 2016, Circulation research.

[27]  Kun-Ling Tsai,et al.  Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling , 2016, Oncotarget.

[28]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[29]  W. Martinet,et al.  Metformin attenuates expression of endothelial cell adhesion molecules and formation of atherosclerotic plaques via autophagy induction , 2016 .

[30]  J. Lalau,et al.  Therapeutic Concentrations of Metformin: A Systematic Review , 2016, Clinical Pharmacokinetics.

[31]  Yongjian Wu,et al.  Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway , 2015, PloS one.

[32]  Shuang Zhou,et al.  Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. , 2015, British journal of clinical pharmacology.

[33]  D. Vestweber,et al.  How leukocytes cross the vascular endothelium , 2015, Nature Reviews Immunology.

[34]  Wai Keung Christopher Lai,et al.  Homocysteine-Induced Endothelial Dysfunction , 2015, Annals of Nutrition and Metabolism.

[35]  Mengwei Zang,et al.  New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells. , 2015, Molecular endocrinology.

[36]  D. Hess,et al.  Forkhead Box O-1 Modulation Improves Endothelial Insulin Resistance in Human Obesity , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[37]  F. Keleştimur,et al.  Metformin improves endothelial function and carotid intima media thickness in patients with PCOS , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[38]  A. Orekhov,et al.  Vascular endothelium: functioning in norm, changes in atherosclerosis and current dietary approaches to improve endothelial function. , 2015, Mini reviews in medicinal chemistry.

[39]  F. Wondisford,et al.  Metformin action: concentrations matter. , 2015, Cell metabolism.

[40]  N. Ruderman,et al.  Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells. , 2015, American journal of physiology. Cell physiology.

[41]  D. Seals,et al.  The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice. , 2014, American journal of physiology. Heart and circulatory physiology.

[42]  C. Baylis,et al.  Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension. , 2014, American journal of physiology. Renal physiology.

[43]  Wenhua Zheng,et al.  Transforming growth factor β‐mediated site‐specific Smad linker region phosphorylation in vascular endothelial cells , 2014, The Journal of pharmacy and pharmacology.

[44]  A. Akhmedov,et al.  Carbamylated low-density lipoprotein induces endothelial dysfunction. , 2014, European heart journal.

[45]  Linnea Eriksson,et al.  Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis , 2014, Cardiovascular Diabetology.

[46]  Yoshimasa Tanaka,et al.  Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention , 2014, International journal of medical sciences.

[47]  H. Westerblad,et al.  TNF-α-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes. , 2014, Cardiovascular research.

[48]  Jing Zhao,et al.  An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E-/- mice , 2014, Scientific Reports.

[49]  A. J. Valente,et al.  OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators. , 2014, Free radical biology & medicine.

[50]  X. Tian,et al.  Metformin Protects Endothelial Function in Diet-Induced Obese Mice by Inhibition of Endoplasmic Reticulum Stress Through 5′ Adenosine Monophosphate–Activated Protein Kinase–Peroxisome Proliferator–Activated Receptor &dgr; Pathway , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[51]  Suowen Xu,et al.  Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis. , 2014, International journal of cardiology.

[52]  D. Bernhard,et al.  Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[53]  P. Davoren.  Safe prescribing of metformin in diabetes , 2014 .

[54]  H. Jacob,et al.  Amelioration of salt-induced vascular dysfunction in mesenteric arteries of Dahl salt-sensitive rats by missense mutation of extracellular superoxide dismutase. , 2014, American journal of physiology. Heart and circulatory physiology.

[55]  D. Noonan,et al.  Paradoxic effects of metformin on endothelial cells and angiogenesis , 2014, Carcinogenesis.

[56]  A. Donker,et al.  Long‐term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial , 2014, Journal of internal medicine.

[57]  S. Samuel,et al.  Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1 , 2013, British journal of pharmacology.

[58]  C. Zuurbier,et al.  Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice , 2013, Cardiovascular Diabetology.

[59]  C. Sena,et al.  Endothelial dysfunction - a major mediator of diabetic vascular disease. , 2013, Biochimica et biophysica acta.

[60]  G. Azhar,et al.  Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[61]  Jian-Mei Li,et al.  Crucial roles of Nox2‐derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle‐aged mice , 2013, British journal of pharmacology.

[62]  Emiri T. Mandeville,et al.  Deficient eNOS Phosphorylation Is a Mechanism for Diabetic Vascular Dysfunction Contributing to Increased Stroke Size , 2013, Stroke.

[63]  K. Channon,et al.  Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.

[64]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[65]  F. Crea,et al.  Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo‐controlled randomized study , 2013, Diabetes, obesity & metabolism.

[66]  S. Dohgu,et al.  Metformin induces up-regulation of blood-brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells. , 2013, Biochemical and biophysical research communications.

[67]  M. Barton.  Prevention and endothelial therapy of coronary artery disease. , 2013, Current opinion in pharmacology.

[68]  Traci L. Marin,et al.  AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6 , 2013, Proceedings of the National Academy of Sciences.

[69]  N. Ruderman,et al.  Protein Kinase C-&bgr; Contributes to Impaired Endothelial Insulin Signaling in Humans With Diabetes Mellitus , 2012, Circulation.

[70]  Luo.  Exposure to High or Low Glucose Levels Accelerates the Appearance of Markers of Endothelial Cell Senescence and Induces Dysregulation of Nitric Oxide Synthase , 2013 .

[71]  R. Muniyappa,et al.  Role of insulin resistance in endothelial dysfunction , 2013, Reviews in Endocrine and Metabolic Disorders.

[72]  J. Moss,et al.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers , 2012, Cellular and Molecular Life Sciences.

[73]  R. Altman,et al.  Metformin pathways: pharmacokinetics and pharmacodynamics , 2012, Pharmacogenetics and genomics.

[74]  C. Siu,et al.  Association of lower habitual physical activity level with mitochondrial and endothelial dysfunction in patients with stable coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[75]  M. Bennett,et al.  Aging and Atherosclerosis: Mechanisms, Functional Consequences, and Potential Therapeutics for Cellular Senescence , 2012, Circulation research.

[76]  S. Hasanzadeh,et al.  An investigation on body weights, blood glucose levels and pituitary-gonadal axis hormones in diabetic and metformin-treated diabetic female rats , 2012, Veterinary research forum : an international quarterly journal.

[77]  K. Griendling,et al.  Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System , 2012, Circulation research.

[78]  R. Fernandes,et al.  Methylglyoxal promotes oxidative stress and endothelial dysfunction. , 2012, Pharmacological research.

[79]  K. Nakajima,et al.  The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts , 2012, Cell cycle.

[80]  R. Touyz,et al.  Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. , 2012, Basic & clinical pharmacology & toxicology.

[81]  M. White,et al.  Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)* , 2011, The Journal of Biological Chemistry.

[82]  Per Damkier,et al.  The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c , 2011, Pharmacogenetics and genomics.

[83]  K. Kamata,et al.  Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats. , 2011, American journal of physiology. Heart and circulatory physiology.

[84]  C. Garland,et al.  EDHF: spreading the influence of the endothelium , 2011, British journal of pharmacology.

[85]  A. Chait,et al.  Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. , 2011, Pharmacology & therapeutics.

[86]  H. Schmidt,et al.  Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy. , 2011, American journal of physiology. Heart and circulatory physiology.

[87]  M. Félétou.  The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway" , 2011 .

[88]  C. Sobey,et al.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets , 2011, Nature Reviews Drug Discovery.

[89]  L. Ignarro,et al.  Dose-Dependent Modulatory Effects of Insulin on Glucose-Induced Endothelial Senescence In Vitro and In Vivo: A Relationship between Telomeres and Nitric Oxide , 2011, Journal of Pharmacology and Experimental Therapeutics.

[90]  R. Fernandes,et al.  Metformin restores endothelial function in aorta of diabetic rats , 2011, British journal of pharmacology.

[91]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[92]  D. Seals,et al.  Salicylate treatment improves age-associated vascular endothelial dysfunction: potential role of nuclear factor kappaB and forkhead Box O phosphorylation. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[93]  J. Campisi,et al.  Four faces of cellular senescence , 2011, The Journal of cell biology.

[94]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[95]  S. Lehoux,et al.  Characterization of the Differential Response of Endothelial Cells Exposed to Normal and Elevated Laminar Shear Stress , 2011, Journal of cellular physiology.

[96]  G. Chrousos,et al.  Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. , 2011, Fertility and sterility.

[97]  S. Cernea.  The role of incretin therapy at different stages of diabetes. , 2011, The review of diabetic studies : RDS.

[98]  S. Chien,et al.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.

[99]  P. Little,et al.  Transforming growth factor‐β regulation of proteoglycan synthesis in vascular smooth muscle: Contribution to lipid binding and accelerated atherosclerosis in diabetes , 2010, Journal of diabetes.

[100]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[101]  M. Nurmohamed,et al.  Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus , 2010, Mediators of inflammation.

[102]  C. Kahn,et al.  Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. , 2010, Cell metabolism.

[103]  J. -. Park,et al.  TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL , 2010, Cell Death and Differentiation.

[104]  G. Paolisso,et al.  Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations. , 2010, Journal of diabetes and its complications.

[105]  M. Ludgate,et al.  Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. , 2009, The Journal of clinical endocrinology and metabolism.

[106]  T. Michel,et al.  Cellular signaling and NO production , 2010, Pflügers Archiv - European Journal of Physiology.

[107]  J. Loscalzo,et al.  Oxidative risk for atherothrombotic cardiovascular disease. , 2009, Free radical biology & medicine.

[108]  L. Ghiadoni,et al.  Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease , 2009, Diabetes Care.

[109]  B. Viollet,et al.  In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I , 2009, Diabetes.

[110]  C. Nacci,et al.  Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. , 2009, Current medicinal chemistry.

[111]  J. Erusalimsky.  Vascular endothelial senescence: from mechanisms to pathophysiology. , 2009, Journal of applied physiology.

[112]  A. Avogaro,et al.  Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. , 2008, Diabetes research and clinical practice.

[113]  F. Visseren,et al.  Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. , 2008, European heart journal.

[114]  P. Little,et al.  Hyperelongated biglycan: the surreptitious initiator of atherosclerosis , 2008, Current opinion in lipidology.

[115]  A. Janež,et al.  Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome. , 2008, European journal of endocrinology.

[116]  Q. Pan,et al.  Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose , 2008, Apoptosis.

[117]  Y. Ouchi,et al.  Cilostazol Inhibits Oxidative Stress–Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[118]  Y. Yoon,et al.  Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. , 2008, Cardiovascular research.

[119]  H. Tse,et al.  Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-κB pathway , 2008, Diabetologia.

[120]  W. Arendshorst,et al.  Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors. , 2008, American journal of physiology. Renal physiology.

[121]  R. Fernandes,et al.  Effects of α‐lipoic acid on endothelial function in aged diabetic and high‐fat fed rats , 2008 .

[122]  M. Zou,et al.  Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-&zgr; Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial Cells , 2008, Circulation.

[123]  P. Sipkema,et al.  Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity , 2008, Cell and Tissue Research.

[124]  R. Testa,et al.  Pathogenetic Loop Between Diabetes and Cell Senescence , 2007, Diabetes Care.

[125]  P. Little,et al.  Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions , 2007, Cardiovascular diabetology.

[126]  J. Borén,et al.  Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update , 2007 .

[127]  A. Shoukas,et al.  Inducible NO Synthase–Dependent S-Nitrosylation and Activation of Arginase1 Contribute to Age-Related Endothelial Dysfunction , 2007, Circulation research.

[128]  Y. Naito,et al.  Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. , 2007, Atherosclerosis.

[129]  Z. Ungvari,et al.  Increased mitochondrial H2O2 production promotes endothelial NF- B activation in aged rat arteries , 2007 .

[130]  Jason R. Kosky,et al.  The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress. , 2007, Biochemical and biophysical research communications.

[131]  C. Caruso,et al.  Inflammatory networks in ageing, age-related diseases and longevity , 2007, Mechanisms of Ageing and Development.

[132]  P. Vanhoutte,et al.  Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). , 2006, American journal of physiology. Heart and circulatory physiology.

[133]  Kunihiro Suzuki,et al.  Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.

[134]  Toshio Ogihara,et al.  Apoptosis Signal-Regulating Kinase 1 Mediates Cellular Senescence Induced by High Glucose in Endothelial Cells , 2006, Diabetes.

[135]  F. Faraci,et al.  Endothelium-Derived Hyperpolarizing Factor: Where Are We Now? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[136]  A. Dart,et al.  Insulin resistance and atherosclerosis. , 2006, Endocrine reviews.

[137]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[138]  Wan-Wan Lin,et al.  High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. , 2006, Cellular signalling.

[139]  R. Esper,et al.  Endothelial dysfunction: a comprehensive appraisal , 2006, Cardiovascular diabetology.

[140]  B. Viollet,et al.  Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. , 2006, Diabetes.

[141]  Peter Libby,et al.  Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.

[142]  James L. Young,et al.  Metformin Inhibits Proinflammatory Responses and Nuclear Factor-&kgr;B in Human Vascular Wall Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[143]  P. Libby,et al.  Vascular endothelium and atherosclerosis. , 2006, Handbook of experimental pharmacology.

[144]  C. Telleria,et al.  Cell death induced by serum deprivation in luteal cells involves the intrinsic pathway of apoptosis. , 2006, Reproduction.

[145]  G. FitzGerald,et al.  Eicosanoids and the vascular endothelium. , 2006, Handbook of experimental pharmacology.

[146]  Merlin C. Thomas,et al.  Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells. , 2005, Kidney international.

[147]  P. Ježek,et al.  Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. , 2005, The international journal of biochemistry & cell biology.

[148]  G. Rosano,et al.  Metformin improves endothelial function in patients with metabolic syndrome , 2005, Journal of internal medicine.

[149]  A. Shah,et al.  NADPH oxidase and endothelial cell function. , 2005, Clinical science.

[150]  X. Leverve,et al.  Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. , 2005, Diabetes.

[151]  W. Aird,et al.  Endothelial cell gene regulation. , 2005, Trends in cardiovascular medicine.

[152]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[153]  R. de Caterina,et al.  Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants , 2005, European journal of clinical investigation.

[154]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[155]  M. Cooper,et al.  Advanced-glycation end products in insulin-resistant states , 2005, Current hypertension reports.

[156]  T. Sawamura,et al.  C-Reactive Protein Enhances LOX-1 Expression in Human Aortic Endothelial Cells: Relevance of LOX-1 to C-Reactive Protein–Induced Endothelial Dysfunction , 2004, Circulation research.

[157]  D. Tsikas,et al.  Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometry. , 2004, Nitric oxide : biology and chemistry.

[158]  D. Giugliano,et al.  Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase , 2004, Journal of thrombosis and haemostasis : JTH.

[159]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[160]  P. Vanhoutte,et al.  EDHF: new therapeutic targets? , 2004, Pharmacological research.

[161]  Joseph Avruch,et al.  Insulin signal transduction through protein kinase cascades , 1998, Molecular and Cellular Biochemistry.

[162]  Ernesto L. Schiffrin,et al.  Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.

[163]  E. Schiffrin,et al.  Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.

[164]  E. Salpeter,et al.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. , 2003, Archives of internal medicine.

[165]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[166]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[167]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[168]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[169]  W. Hsueh,et al.  Role of endothelial dysfunction in insulin resistance. , 2003, The American journal of cardiology.

[170]  N. Wiernsperger,et al.  Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation , 2003 .

[171]  H. Morawietz,et al.  NADPH oxidase in endothelial cells: impact on atherosclerosis. , 2003, Antioxidants & redox signaling.

[172]  I. Komuro,et al.  Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.

[173]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[174]  M. Quon,et al.  Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[175]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[176]  G. King,et al.  Protein kinase C and the development of diabetic vascular complications , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[177]  C. Haudenschild,et al.  Endothelium and Atherogenesis: Endothelial Therapy Revisited , 2001, Journal of cardiovascular pharmacology.

[178]  S. Dimmeler,et al.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.

[179]  P. Ridker,et al.  Novel clinical markers of vascular wall inflammation. , 2001, Circulation research.

[180]  A. Zeiher,et al.  Aging Enhances the Sensitivity of Endothelial Cells Toward Apoptotic Stimuli: Important Role of Nitric Oxide , 2001, Circulation research.

[181]  C. Esposito,et al.  Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. , 2001, Kidney international.

[182]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[183]  K. Mather,et al.  Improved endothelial function with metformin in type 2 diabetes mellitus. , 2001, Journal of the American College of Cardiology.

[184]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[185]  P. Fasching,et al.  Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. , 2000, Diabetes.

[186]  S. Chakrabarti,et al.  Interaction of Endothelin-1 with Vasoactive Factors in Mediating Glucose-Induced Increased Permeability in Endothelial Cells , 2000, Laboratory Investigation.

[187]  N. Vaziri,et al.  Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. , 2000, American journal of physiology. Endocrinology and metabolism.

[188]  M. White,et al.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. , 1999, The Journal of clinical investigation.

[189]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[190]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[191]  H. Drexler,et al.  Factors involved in the maintenance of endothelial function. , 1998, The American journal of cardiology.

[192]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[193]  B. Gallacher,et al.  Glucose-Induced Protein Kinase C Activation Regulates Vascular Permeability Factor mRNA Expression and Peptide Production by Human Vascular Smooth Muscle Cells In Vitro , 1997, Diabetes.

[194]  M. Villalobos,et al.  A comparison of p53 and p16 expression in human tumor cells treated with hyperthermia or ionizing radiation , 1997, International journal of cancer.

[195]  S. Haffner.  The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease , 1997, Diabetes Care.

[196]  G. King,et al.  Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells , 1996, British journal of pharmacology.

[197]  G Dailey,et al.  Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[198]  E. Arnold,et al.  Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. , 1994, The American journal of physiology.

[199]  C. Bailey,et al.  Accumulation of metformin by tissues of the normal and diabetic mouse. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[200]  M. Huijberts,et al.  Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. , 1993, The Journal of clinical investigation.

[201]  R M Nerem,et al.  Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. , 1992, The Journal of clinical investigation.

[202]  J. Sixma,et al.  Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions , 1992, Circulation.

[203]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[204]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[205]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[206]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[207]  E. Kruithof,et al.  Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. , 1987, Blood.

[208]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[209]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[210]  F. Murad,et al.  Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP , 1983, Circulation research.

[211]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[212]  J. Vane,et al.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.

[213]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.